Mink Therapeutics Current Valuation vs. Shares Owned By Institutions
| INKT Stock | USD 0.68 0.01 1.49% |
For Mink Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Mink Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Mink Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Mink Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Mink Therapeutics over time as well as its relative position and ranking within its peers.
Mink |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mink Therapeutics. If investors know Mink will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mink Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.48) | Return On Assets (0.97) | Return On Equity (12.39) |
The market value of Mink Therapeutics is measured differently than its book value, which is the value of Mink that is recorded on the company's balance sheet. Investors also form their own opinion of Mink Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Mink Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mink Therapeutics' market value can be influenced by many factors that don't directly affect Mink Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mink Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mink Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mink Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Mink Therapeutics Shares Owned By Institutions vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Mink Therapeutics's current stock value. Our valuation model uses many indicators to compare Mink Therapeutics value to that of its competitors to determine the firm's financial worth. Mink Therapeutics is rated below average in current valuation category among its peers. It is rated below average in shares owned by institutions category among its peers . The ratio of Current Valuation to Shares Owned By Institutions for Mink Therapeutics is about 9,607,670 . Comparative valuation analysis is a catch-all technique that is used if you cannot value Mink Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Mink Current Valuation vs. Competition
Mink Therapeutics is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 47.41 Billion. Mink Therapeutics adds roughly 22.1 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Mink Shares Owned By Institutions vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Mink Therapeutics |
| = | 22.1 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Mink Therapeutics |
| = | 2.30 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Mink Shares Owned By Institutions Comparison
Mink Therapeutics is currently under evaluation in shares owned by institutions category among its peers.
Mink Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Mink Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Mink Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Mink Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Mink Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -430.9 K | -452.5 K | |
| Net Interest Income | 556.6 K | 584.4 K | |
| Operating Income | -22.9 M | -24.1 M | |
| Net Loss | -24.8 M | -26 M | |
| Income Before Tax | -22.5 M | -23.6 M | |
| Total Other Income Expense Net | 463.2 K | 486.4 K | |
| Net Loss | -25.2 M | -26.5 M | |
| Net Loss | -22.5 M | -23.6 M | |
| Income Tax Expense | 3.00 | 3.15 | |
| Interest Income | 463.3 K | 394.1 K | |
| Non Operating Income Net Other | 2.4 M | 2.2 M | |
| Change To Netincome | 3.5 M | 6.7 M | |
| Net Loss | (0.65) | (0.69) | |
| Income Quality | 0.70 | 0.47 | |
| Net Income Per E B T | 0.89 | 1.02 |
Mink Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Mink Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Mink Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Mink Therapeutics' important profitability drivers and their relationship over time.
Use Mink Therapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mink Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will appreciate offsetting losses from the drop in the long position's value.Mink Therapeutics Pair Trading
Mink Therapeutics Pair Trading Analysis
The ability to find closely correlated positions to Mink Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mink Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mink Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mink Therapeutics to buy it.
The correlation of Mink Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mink Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mink Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mink Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Mink Therapeutics position
In addition to having Mink Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Heavy Metals Thematic Idea Now
Heavy Metals
Companies involved in mining, production, and distribution of various industrial metals and minerals. The Heavy Metals theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Heavy Metals Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Mink Stock Analysis
When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.